Animal demographics and identification with B-LCL doses.

Intravenous (IV)1, IV2, IV3: Doses of infused B-LCL (x106 viable cells) pulsed with the indicated peptides (group A: MOG34–56, group B: CMVmcp981–1003 and group C: citrullinated MOG34–56) are given for each infusion. Values in bold indicate that dead B-LCL were removed before pulsing with peptide by density gradient centrifugation. None of the parameters differed significantly between the groups.静脉注射（Intravenous, IV）1、IV2、IV3组：每次输注均给予经指定肽段脉冲致敏的输注用B淋巴母细胞样细胞系（B-LCL），剂量以x10^6个活细胞计，肽段分为三组：A组为MOG34–56，B组为CMVmcp981–1003，C组为瓜氨酸化MOG34–56。加粗数值代表在肽段脉冲致敏前，通过密度梯度离心法去除了死B-LCL的组别。各组间各项参数均无显著差异。